Stifel analyst Mathew Blackman reiterated a Buy rating and $17.00 price target on Clearpoint Neuro Inc. (NASDAQ: CLPT).He said, "It's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE